Alzheimer's disease News
|
A group of scientists and advocates have come together to crowdsource a new approach progress leapfrog scientific understanding and to side-step the obstacles for researching Alzheimer’s disease.
|
|
Those considered at risk from Alzheimer's disease, and perform moderate-intensity physical activity, appear more likely to have a glucose metabolism in their brain. Such a pattern is associated with a lower risk of Alzheimer's development.
|
|
Leicester -
British scientists think they are on a path to developing a drug that can stop all neurodegenerative brain diseases, including dementia. The drug stops brain cells from dying.
|
|
Toronto -
There are a lot of ways you could categorize Robert Lepage’s spellbinding “887” – magic show? Confessional monologue? History lesson? – and none would be wrong. But only by blending these unlikely elements does it become a masterwork.
|
|
News that pharmaceutical company Merck has halted a clinical trial for a once promising Alzheimer’s treatment (verubecestat) is not only bad news for the patient group, it could signal that the general view as to the cause of Alzheimer's might be wrong.
|
|
Brain tissue could be "programmed" for life during early development in the womb and during infancy. One key factor is Vitamin A, and deficiency could be linked to developing Alzheimer's disease later in life.
|
|
Is there a link between concussion and the later development of Alzheimer’s disease? Although there are different factors that could result in the neurodegenerative disease, researchers, in a new report, focus on one potentially important aspect.
|
|
Linking honeybees to Alzheimer’s disease sounds, first off, like a leap too far. However, scientists have how understanding memory in honeybees could help to combat degenerative brain diseases.
|
|
In a breakthrough, medical scientists have drawn a connection between parts of the brainstem and problems associated with bone, in relation to Alzheimer’s disease.
|
|
A straightforward test to detect Alzheimer’s disease based on the analysis of a sample of saliva has been developed. The test can also provide clues about the development of the disease where the result is positive.
|
|
A process called nucleation describes everything from the formation of champagne bubbles to the onset of Alzheimer’s disease. This physical and chemical process is being studied by researchers interested in disease development.
|
|
A new drug has been developed, designed to clear up plaques of beta amyloid protein that build-up in patients who have different stages of Alzheimer’s disease. The drug may play a role in slowing down disease progression.
|
|
New research, based on small sample of adults, indicates that cortical amyloid levels in the brain a marker of preclinical Alzheimer disease has an associated with self-reported loneliness.
|
|
A new ‘smart’ toy has been devised to give to Alzheimer’s and dementia patients. The toy is designed to ‘smooth’ the patients and the smart functionality adds therapeutic capabilities.
|
|
A drug delivery mechanism intended for the treatment of a form of cancer may have effectiveness at slowing down the effects of Alzheimer’s disease, according to a new research study.
|
|
A sensor has been devised to detect for vitamin B12 deficiency. A lack of this vitamin has been linked with a higher risk of dementia and Alzheimer's disease.
|
|
The tau protein has been implicated in Alzheimer’s disease. However, there has been, until now, little research about how then protein contributes to memory loss. A new theory has been proposed.
|
|
Building surfaces as complex as insect wings allows for advanced research into light scattering, techniques that might shine a spotlight on the assessing the developed of Alzheimer’s disease early.
|
|
There have been many encouraging studies on Alzheimer's Disease and other dementia in recent years, but a new study out of the U.K. could be the most promising yet. The study found that an existing drug may be applied to Alzheimer's to great effect.
|
|
Medical researchers have devised a new imaging method to track genetic markers in the human brain. Abnormalities with these genes are indicators of potential neurodegenerative diseases like Alzheimer’s.
|
|
Toronto -
Toronto-based Vielight Inc. has produced two wearable technology devices that have the potential to help people affected by Alzheimer’s disease.
|
|
Chicago -
In a potentially significant breakthrough, a long dose of antibiotics has reduced Alzheimer’s-related plaques in studies using mice.
|
|
There’s a lot written about Alzheimer’s disease and the attempts to find treatments. Little is written, however, from the patient’s perspective. One man, with Alzheimer’s, is seeking to change this and offer a unique insight into the condition.
|
|
Australian researchers have found a connection between early onset Alzheimer’s disease and a type of genetic mutation. This could signal a new direction for research into the disease.
|
|
There are several possible causes of Alzheimer’s disease. One are being looked at by medical researchers is a possible connection between the neurodegenerative disease and certain infections.
|
|
A team of German, Swedish and Italian researchers from Örebro University found a new strategy to slow down Alzheimer's Disease (AD) progression. They tried an old drug (clopidogrel) to test out a new therapeutic strategy.
|
|
An alarming new study indicates that the newer generation of fungicides could be linked to conditions like autism and various neurodegenerative diseases. The study is based on an animal model.
|
|
A possible connection between viral and bacterial pathogens and the neurodegenerative disorder Alzheimer's disease has been made by a research group. While not definitive, the research opens up a new area to investigate.
|
|
To speed up the process of studying neurological diseases, and to investigate novel treatments, researchers are creating "mini-brains" in the laboratory. These are composed of the neurons and cells found in the human brain.
|
|
Cambridge -
New experiments have indicated a number of drugs that could help protect against Alzheimer's disease. The drugs act like statins for the brain.
|
apis-345618 apis-339000 apis-332919 apis-331932 apis-327808 apis-326906 apis-325383 apis-323367 apis-322450 apis-321784 apis-321656 apis-321239 apis-320366 apis-320099 apis-319768 apis-319344 apis-317795 apis-315582 apis-313336 apis-313228 apis-312832 apis-311823 apis-311334 apis-309898 apis-308348 apis-306962 apis-304230 apis-300534 apis-297962 apis-297665
Alzheimer's disease Image
Charlton Heston and Ronald Reagan at a meeting in the White House. Both of them would later be diagnosed with Alzheimer's disease.
Photo taken: June 15, 1981 White House Photo Office
This picture by the National Institute of Health compares a healthy brain to a brain damaged by Alzheimer's Disease. National Institutes of Health
Dr. Olumayokun Olajide's research will now look to produce compound derivatives of punicalagin for a drug that would treat neuro-inflammation, slowing down the progression of Alzheimer's University of Huddersfield
Memory Care Cafe is a support group-based outreach for caregivers of Alzheimer's and their loved ones. Courtesy of Patricia Ris, founder of Memory Care Cafe
Alzheimer's patient Pixabay
PET scans showing the differences between a normal older adult's brain and the brain of an older adult afflicted with Alzheimer's disease. National Institutes of Health
Life size model of fetus at 8 weeks after conception, in hand of adult. Detailed coloring is not shown. This illustrates that fetus has all limbs formed at this stage, and shows size in comparison to that of adult. Wikimedia OTRS system
The skin of the pomegranate is the principal source for punicalagin found to reduce inflammation of brain cells, a contributory factor in the onset of Alzheimer's disease. University of Huddersfield
A Therapal recreates the beneficial sensations of animal therapy by detecting tactile input from a patient, and responds by generating soothing vibrations, in addition to an underlying heartbeat. Therapalz
The O'Brien family, with Greg O'Brien at the far left of the photograph. Courtesy of Greg O'Brien
The Vielight Neuro is designed to direct pulsed near infrared light (NIR) to the targeted brain hubs through a safe, portable device. Vielight
PET scans showing the differances between a normal older adult's brain and the brain of an older adult afflicted with Alzheimer's disease. — On photo (left to right): PET scan of normal brain, PET scan of Alzheimer’s disease brain. National Institutes of Health
|
|
